Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial

American Journal of Obstetrics and Gynecology(2020)10.1016/j.ajog.2020.04.006Source: DataRank Database

Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial is a research paper published in American Journal of Obstetrics and Gynecology (2020). On theSindex it has a DataRank of 0. It has been cited 47 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access47 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 4.60)OA: greenTopics (56)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Nathanael Koelper ORCID,Mitchell D. Creinin ORCID,Jessica Atrio ORCID,Mary D. Sammel ORCID,Arden McAllister ORCID

Live enrichment

PubMed:32305259 PMC:PMC7529708 OpenAlex:https://openalex.org/W3016966753

NICHD NIH HHS

Grant: R01 HD071920

NICHD NIH HHS

Grant: K12 HD001265

National Institutes of Health

Grant: 1K04HD000719-01

BEHAVIORAL BIOLOGY OF THE FETUS

National Institutes of Health

Grant: 5K12HD001265-09

Center for Career Development in Womens Health

National Institutes of Health

FWCI

4.60

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7529708

publisherhttps://api.elsevier.com/content/article/PII:S0002937820304312?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0002937820304312?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ajog.2020.04.006

Fields of Study

Reproductive Health and ContraceptionReproductive System and PregnancyMaternal and fetal healthcare03 medical and health sciences0302 clinical medicine

MeSH Terms

Abortifacient Agents, NonsteroidalAbortifacient Agents, SteroidalAbortion, SpontaneousAdultDrug Therapy, CombinationFemaleHumansParityPregnancyUterine HemorrhageMifepristoneMisoprostolTreatment Outcome

Keywords

MisoprostolMedicinePregnancyMifepristoneObstetricsEarly Pregnancy LossRegimenRandomized controlled trialGestational ageAbortionGynecologySurgeryMedical ManagementAdultClinical Trials and Supportive ActivitiesSteroidalReproductive health and childbirthPaediatrics and Reproductive MedicineDrug TherapyClinical ResearchHumansObstetrics & Reproductive MedicineAbortifacient Agents, NonsteroidalBiomedical and Clinical SciencesAbortifacient AgentsSpontaneousAbortifacient Agents, SteroidalEvaluation of treatments and therapeutic interventionsAbortion, SpontaneousParityTreatment OutcomeReproductive Medicine6.1 PharmaceuticalsCombinationDrug Therapy, CombinationFemaleUterine HemorrhageNonsteroidal

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Reduced inequalities

Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial

FAIR Checklist

Authors (7)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)